Compare Exelon Corporation Common Stock (EXC) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelon Corporation Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Exelon Corporation Common Stock trades at $41.76 (market cap $42.99B), while Halozyme Therapeutics Inc. Common Stock trades at $112.19 (market cap $12.58B). The key difference: Exelon Corporation Common Stock is far larger — about 3.4× Halozyme Therapeutics Inc. Common Stock's market cap, and Exelon Corporation Common Stock pays a 4.03% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| EXC | HALO | |
|---|---|---|
Market Cap | $42.99B | $12.58B |
Volume | 7,570,408 | 2,179,278 |
Sector | Utilities | Health |
52-Week High | $50.29 | $115.22 |
52-Week Low | $40.20 | $61.63 |
Enterprise Value | $93.85B | $14.49B |
Dividend Yield | 4.03% | — |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Exelon Corporation Common Stock
Exelon is the parent company of six regulated electric and natural gas utilities. Its utilities include Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco.
Read more on EXC →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
